Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD)

PY Wen, TF Cloughesy, BM Ellingson, DA Reardon, HA Fine, L Abrey, K Ballman, M Bendszuz, J Buckner, SM Chang, MD Prados, WB Pope, AG Sorensen, Martin van den Bent, WKA Yung

Research output: Contribution to journalArticleAcademicpeer-review

43 Citations (Scopus)

Abstract

On January 30, 2014, a workshop was held on neuroimaging endpoints in high-grade glioma. This workshop was sponsored by the Jumpstarting Brain Tumor Drug Development Coalition, consisting of the National Brain Tumor Society, the Society for Neuro-Oncology, Accelerate Brain Cancer Cure, and the Musella Foundation for Research and Information, and conducted in collaboration with the Food and Drug Administration. The workshop included neuro-oncologists, neuroradiologists, radiation oncologists, neurosurgeons, biostatisticians, patient advocates, and representatives from industry, clinical research organizations, and the National Cancer Institute. This report summarizes the presentations and discussions of that workshop and the proposals that emerged to improve the Response Assessment in Neuro-Oncology (RANO) criteria and standardize neuroimaging parameters.
Original languageUndefined/Unknown
Pages (from-to)36-47
Number of pages12
JournalNeuro-Oncology
Volume16
DOIs
Publication statusPublished - 2014

Research programs

  • EMC MM-03-44-06

Cite this